Cadence Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-5,473
Closed -$488K 719
2017
Q1
$488K Buy
+5,473
New +$450K 0.03% 525
2016
Q4
Sell
-2,620
Closed -$207K 721
2016
Q3
$207K Sell
2,620
-1,093
-29% -$93.2K 0.02% 607
2016
Q2
$337K Buy
3,713
+60
+2% +$5.08K 0.03% 515
2016
Q1
$310K Sell
3,653
-34
-0.9% -$2.53K 0.02% 555
2015
Q4
$291K Buy
3,687
+34
+0.9% +$2.68K 0.02% 551
2015
Q3
$257K Buy
+3,653
New +$301K 0.02% 549
2015
Q2
Sell
-40,170
Closed -$4.04M 703
2015
Q1
$4.04M Sell
40,170
-10,570
-21% -$1.07M 0.25% 111
2014
Q4
$5.1M Sell
50,740
-50
-0.1% -$4.98K 0.3% 93
2014
Q3
$4.89M Sell
50,790
-16,280
-24% -$1.54M 0.26% 114
2014
Q2
$6.25M Buy
+67,070
New +$5.86M 0.3% 101

Other funds holding MJN

Cadence Capital Management's MJN Position: Q2 2017 in Review

Cadence Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 5,473 shares — an estimated $488K sold.

Cadence Capital Management first reported a position in MJN in Q2 2014 and held it in 10 quarters. The position peaked at $6.25M in Q2 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Cadence Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Cadence Capital Management sold 5,473 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $488K.
  • Cadence Capital Management first reported a position in Mead Johnson Nutrition Company in Q2 2014 and held it in 10 quarters.
  • Cadence Capital Management's Mead Johnson Nutrition Company position peaked at $6.25M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Cadence Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.